New Strong Buy Stocks for December 24th

Zacks
24 Dec 2024

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

TechnipFMC plc FTI: This energy solutions company has seen the Zacks Consensus Estimate for its current year earnings increasing 16.6% over the last 60 days.

TechnipFMC plc Price and Consensus

TechnipFMC plc price-consensus-chart | TechnipFMC plc Quote

NRx Pharmaceuticals, Inc. NRXP: This bio-pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 46.2% over the last 60 days.

NRx Pharmaceuticals, Inc. Price and Consensus

NRx Pharmaceuticals, Inc. price-consensus-chart | NRx Pharmaceuticals, Inc. Quote

Powell Industries, Inc. POWL: This custom equipment manufacturer the Zacks Consensus Estimate for its current year earnings increasing 10.1% over the last 60 days.

Powell Industries, Inc. Price and Consensus

Powell Industries, Inc. price-consensus-chart | Powell Industries, Inc. Quote

Vimeo, Inc. VMEO: This video software solutions company has seen the Zacks Consensus Estimate for its current year earnings increasing 125% over the last 60 days.

Vimeo, Inc. Price and Consensus

Vimeo, Inc. price-consensus-chart | Vimeo, Inc. Quote

Puma Biotechnology, Inc. PBYI: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 14% over the last 60 days.

Puma Biotechnology, Inc. Price and Consensus

Puma Biotechnology, Inc. price-consensus-chart | Puma Biotechnology, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. 

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

TechnipFMC plc (FTI) : Free Stock Analysis Report

Puma Biotechnology, Inc. (PBYI) : Free Stock Analysis Report

Powell Industries, Inc. (POWL) : Free Stock Analysis Report

NRx Pharmaceuticals, Inc. (NRXP) : Free Stock Analysis Report

Vimeo, Inc. (VMEO) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10